$286M
$59,000
0.0% of portfolio
3,798
Q2 2024
Reduced 0.11%
$1.06B
$181,000
0.0% of portfolio
3,509
Q2 2025
Reduced 36.3%
$786M
$169,000
0.0% of portfolio
25,631
Q2 2025
Added 31.08%
$2.75B
$837,000
0.0% of portfolio
58,700
Q3 2024
Reduced 27.71%
-
$270,000
0.0% of portfolio
-
Q3 2024
Reduced 13.39%
$618M
$227,000
0.0% of portfolio
9,202
Q2 2024
Added 0.04%
$274M
$122,000
0.0% of portfolio
60,800
Q2 2025
New
-
$101,000
0.0% of portfolio
-
Q2 2025
New
$1.08B
$893,000
0.0% of portfolio
33,409
Q2 2025
Added 53.19%
$445M
$213,000
0.0% of portfolio
6,900
Q4 2024
Added 2,200.0%
$249M
$105,000
0.0% of portfolio
1,700
Q2 2025
New
$1.41B
$442,000
0.0% of portfolio
2,357
Q3 2024
Reduced 20.29%
$1.65B
$941,000
0.0% of portfolio
38,296
Q2 2025
Added 12.32%
$933M
$292,000
0.0% of portfolio
2,147
Q2 2025
Added 22.9%
-
$2.22 Million
0.0% of portfolio
-
Q1 2025
Reduced 51.45%
-
$2.07 Million
0.0% of portfolio
-
Q1 2025
Reduced 35.15%
$185M
$3,000
0.0% of portfolio
1,042
Q2 2024
Reduced 40.53%
$1.17B
$259,000
0.0% of portfolio
8,125
Q3 2024
Reduced 27.62%
$488M
$3.39 Million
0.0% of portfolio
127,628
Q2 2025
Reduced 22.97%
$397M
$115,000
0.0% of portfolio
5,939
Q3 2024
Reduced 23.26%
$556M
$29,000
0.0% of portfolio
2,387
Q2 2025
Reduced 77.24%
$306M
$29,000
0.0% of portfolio
1,832
Q2 2025
Reduced 78.01%
$2.5B
$1.39 Million
0.0% of portfolio
30,544
Q1 2025
Added 3.38%
$4.83B
$2.32 Million
0.0% of portfolio
23,246
Q2 2025
Added 82.38%
-
$343,000
0.0% of portfolio
-
Q2 2025
New
$584M
$210,000
0.0% of portfolio
5,169
Q3 2024
Reduced 33.47%
$747M
$305,000
0.0% of portfolio
17,753
Q4 2024
Added 53.67%
$146M
$9,000
0.0% of portfolio
1,700
Q3 2024
Reduced 90.0%
$1.52B
$364,000
0.0% of portfolio
17,458
Q3 2024
Reduced 22.95%
$770M
$136,000
0.0% of portfolio
12,384
Q1 2025
Added 57.08%
$473M
$107,000
0.0% of portfolio
3,180
Q2 2024
Added 0.03%
$728M
$240,000
0.0% of portfolio
6,111
Q2 2024
Added 0.03%
$890M
$140,000
0.0% of portfolio
22,959
Q3 2024
Reduced 44.08%
$2.95B
$876,000
0.0% of portfolio
49,500
Q2 2025
Reduced 29.65%
$151M
$58,000
0.0% of portfolio
5,800
Q4 2024
Added 625.0%
$94M
$11,000
0.0% of portfolio
3,600
Q3 2024
Reduced 91.63%
$719M
$1.57 Million
0.0% of portfolio
80,514
Q2 2025
Added 392.77%
$3.29B
$1.91 Million
0.0% of portfolio
62,428
Q2 2025
Added 6.12%
-
$36,000
0.0% of portfolio
-
Q2 2024
Added 71.01%
$3.64B
$862,000
0.0% of portfolio
25,749
Q2 2025
Reduced 14.27%
$627M
$252,000
0.0% of portfolio
5,514
Q2 2024
Added 0.04%
$909M
$137,000
0.0% of portfolio
11,561
Q2 2025
Reduced 43.22%
$479M
$54,000
0.0% of portfolio
3,131
Q2 2025
Reduced 64.94%
$1.09B
$340,000
0.0% of portfolio
11,300
Q2 2025
Reduced 36.84%
Cartesian Therapeutics In
-
$41,000
0.0% of portfolio
-
Q4 2024
Reduced 23.52%
$582M
$140,000
0.0% of portfolio
3,223
Q2 2025
Reduced 42.68%
$2.06B
$1.42 Million
0.0% of portfolio
65,196
Q2 2025
Reduced 29.14%
$3.62B
$2.89 Million
0.0% of portfolio
63,487
Q4 2024
Added 194.1%
$4.82B
$1.16 Million
0.0% of portfolio
2,671
Q4 2024
Reduced 55.59%
$163M
$105,000
0.0% of portfolio
3,700
Q2 2025
New